Travere Therapeutics(TVTX) - 2022 Q1 - Quarterly Report
| | UNITED STATES | | --- | --- | | | SECURITIES AND EXCHANGE COMMISSION | | | WASHINGTON, D.C. 20549 | | | _________________________________ | | | FORM 10-Q | | | _________________________________ | | ☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the quarterly period ended March 31, 2022 | | | or | | ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the transition period from ___________ to ________ ...